Oppenheimer Asset Management Inc. Sells 3,257 Shares of The Pennant Group, Inc. (NASDAQ:PNTG)

Oppenheimer Asset Management Inc. reduced its stake in The Pennant Group, Inc. (NASDAQ:PNTG) by 19.1% during the 4th quarter, HoldingsChannel reports. The firm owned 13,776 shares of the company’s stock after selling 3,257 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in The Pennant Group were worth $365,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of PNTG. FMR LLC grew its position in The Pennant Group by 51.3% during the 3rd quarter. FMR LLC now owns 2,528,512 shares of the company’s stock worth $90,268,000 after acquiring an additional 856,838 shares during the last quarter. Van Berkom & Associates Inc. grew its position in The Pennant Group by 2,635.6% during the 4th quarter. Van Berkom & Associates Inc. now owns 2,198,216 shares of the company’s stock worth $58,297,000 after acquiring an additional 2,117,859 shares during the last quarter. Crewe Advisors LLC grew its position in The Pennant Group by 1.6% during the 3rd quarter. Crewe Advisors LLC now owns 742,958 shares of the company’s stock worth $26,524,000 after acquiring an additional 11,927 shares during the last quarter. Geode Capital Management LLC grew its position in The Pennant Group by 0.4% during the 3rd quarter. Geode Capital Management LLC now owns 682,132 shares of the company’s stock worth $24,357,000 after acquiring an additional 2,963 shares during the last quarter. Finally, De Lisle Partners LLP grew its position in The Pennant Group by 7.6% during the 3rd quarter. De Lisle Partners LLP now owns 343,340 shares of the company’s stock worth $12,254,000 after acquiring an additional 24,321 shares during the last quarter. 85.88% of the stock is currently owned by institutional investors.

The Pennant Group Stock Down 1.5 %

NASDAQ:PNTG opened at $23.10 on Friday. The stock’s fifty day moving average price is $26.27 and its two-hundred day moving average price is $30.31. The Pennant Group, Inc. has a 52-week low of $18.21 and a 52-week high of $37.13. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.12 and a current ratio of 1.12. The company has a market cap of $795.33 million, a price-to-earnings ratio of 33.97, a P/E/G ratio of 2.24 and a beta of 2.06.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Wells Fargo & Company assumed coverage on The Pennant Group in a research report on Thursday, December 19th. They set an “equal weight” rating and a $33.00 price target on the stock. Truist Financial decreased their price target on The Pennant Group from $38.00 to $32.00 and set a “hold” rating on the stock in a research report on Monday, January 6th. Finally, Oppenheimer increased their price target on The Pennant Group from $34.00 to $37.00 and gave the stock an “outperform” rating in a research report on Friday, November 8th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $36.00.

About The Pennant Group

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.